Evidence map›Paper›PMID 40895446›Full record

ArticleJournal of clinical and translational science2025

The translational science promotion and research capacity (T-SPARC) framework: Developing institutional capacity for translational science.

Jessica Sperling, Stella Quenstedt, Kristine Glauber, Perusi B Muhigaba, Eman Ghanem, Tarun Saxena, Vonda Rodriguez, Cinthia Sanchez, F Joseph McClernon

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jessica SperlingClinical and Translational Science Institute, Duke University School of Medicine, Durham, USA.ORCID https://orcid.org/0000-0002-2443-3762
Stella QuenstedtClinical and Translational Science Institute, Duke University School of Medicine, Durham, USA.
Kristine GlauberClinical and Translational Science Institute, Duke University School of Medicine, Durham, USA.ORCID https://orcid.org/0000-0002-1093-6481
Perusi B MuhigabaClinical and Translational Science Institute, Duke University School of Medicine, Durham, USA.ORCID https://orcid.org/0000-0002-5508-5596
Eman GhanemClinical and Translational Science Institute, Duke University School of Medicine, Durham, USA.
Tarun SaxenaClinical and Translational Science Institute, Duke University School of Medicine, Durham, USA.
Vonda RodriguezClinical and Translational Science Institute, Duke University School of Medicine, Durham, USA.
Cinthia SanchezClinical and Translational Science Institute, Duke University School of Medicine, Durham, USA.
F Joseph McClernonClinical and Translational Science Institute, Duke University School of Medicine, Durham, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent years have seen increasing focus, including by the National Institutes for Health (NIH), on developing the field of translational science (TS). TS focuses on improving the process of translational research (TR), including generating knowledge that can facilitate TR across specific diseases or translational stages. With TS as an emerging field, research organizations have an increasing need to understand how to develop capacity for and support the advancement of TS. To support such institutional and infrastructural change, this paper outlines a Translational Science Promotion and Research Capacity (T-SPARC) Framework. The T-SPARC Framework provides a foundation to 1) inform the development of TS-creating and science-supporting interventions and programs, and 2) examine the effectiveness of said interventions and programs. The framework outlines organizational levels that T-SPARC programs can target; mechanisms, or intervention activities, that can foster change; and outcomes, including specific attitudinal or behavioral changes, institutional changes, and domains on which TS changes can focus. T-SPARC's capacity-building focus builds upon earlier efforts focused on conceptualizing and defining TS. T-SPARC supports movement towards TS goals of reducing longstanding challenges in the TR process, thus accelerating the health impact of TR, and ultimately improving health outcomes.

Indexed as

capacity-buildingframeworkresearch capacityTranslational researchtranslational science

Identifiers

PMID40895446
PMCPMC12392354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.